Should You Buy Carter Bankshares, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Carter Bankshares, Inc. (CARE) is rated as a strong fundamental performer with a QOC score of 8.3/10. Trading at $31.19, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 3 of 6 CirclFi valuation models project upside for Carter Bankshares, Inc. (CARE) at $31.19 — the models are evenly split, with a Quality Score of 8.3/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Carter Bankshares, Inc. (CARE) in 2026?
What Is the Bull Case vs the Bear Case for Carter Bankshares, Inc. (CARE)?
| Bull case — $98.41 target (+215.5%) | Bear case — $8.79 target (-71.8%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Carter Bankshares, Inc.'s score of 8.3/10 reflects durable competitive advantages that should sustain earnings power through market cycles. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $8.79 (-71.8%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model targets a fair value of $98.41 (+215.5%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +287.4% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: credit quality trends could provide meaningful support for Carter Bankshares, Inc.'s revenue and margin trajectory in the Banks - Regional space. | Industry headwind: credit cycle deterioration represents a meaningful risk for Carter Bankshares, Inc. and its Banks - Regional peers. |
How Does CARE Compare to Its Banks - Regional Peers?
Valuation data pages: LOB · PLBC · AX · FULT · CWBC · RBKB · ACNB · BAP · ORRF · STBA · ESQ
Which Other Stocks Score Like CARE on Quality?
Closest companies to CARE’s Quality of Company score of 8.3/10, across all industries.
- SON — Sonoco Products Company (QOC 8.3) · analysis
- WWW — Wolverine World Wide, Inc. (QOC 8.3) · analysis
- MALG — Microalliance Group Inc. (QOC 8.3) · analysis
- BILI — Bilibili Inc. (QOC 8.3) · analysis
- CIEN — Ciena Corporation (QOC 8.3) · analysis
- DFIN — Donnelley Financial Solutions, Inc. (QOC 8.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Banks - Regional Screens Does CARE Appear In?
So Is Carter Bankshares, Inc. (CARE) Worth Buying in 2026?
Our models don't have a clear verdict on Carter Bankshares, Inc.. At $31.19 vs. $28.93 median fair value, the median upside of -7.3% masks significant model disagreement (+287.4% spread). With quality at 8.3/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Carter Bankshares, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About CARE Stock?
Should I buy CARE stock right now?
Based on CirclFi's multi-model analysis, 3 of 6 models see upside for CARE at $31.19. The models are divided, which means the investment case depends heavily on your assumptions about Carter Bankshares, Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Carter Bankshares, Inc.?
Key risks include: limited model coverage (6/13 active), reducing analytical confidence; wide model disagreement (1020% spread), signaling high uncertainty; general market and sector-specific risks affecting Banks - Regional companies. Always diversify and consult a financial advisor.
How does CARE compare to its competitors?
Among Banks - Regional peers, CARE holds a Quality Score of 8.3/10. Comparable companies include LOB (QOC 8.3), PLBC (QOC 8.3), AX (QOC 8.3). The relative ranking helps investors identify whether CARE offers better fundamental quality than alternatives in the same sector.
Is CARE a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CARE's Quality Score of 8.3/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy CARE at?
CirclFi does not provide target buy prices or price alerts. However, our 6 active models produce fair value estimates ranging from $8.79 to $98.41. At $31.19, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CARE.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad